The Accrual to Clinical Trials (ACT) Network is a real-time platform to explore the feasibility for clinical studies across the NCATS Clinical and Translational Science Award consortium. ACT helps researchers design and complete clinical studies and is secure, HIPAA-compliant and IRB-approved.
ACT was developed collaboratively by members of NCATS’ Clinical and Translational Science Award consortium, with funding from the NIH National Center for Advancing Translational Sciences.
Tufts CTSI Affiliated clinical researchers and study teams can now query nearly 40 million patient records through the Accrual to Clinical Trials (ACT) Network for discovery, exploration, and validation of patient cohorts for investigator-initiated multi-site or single-site clinical trials.
- Explore patient populations: Learn about a patient population and search for patients across the CTSA network to identify potential partners for multi-site studies.
- Check the feasibility of clinical studies: Iteratively test and refine inclusion and exclusion criteria to confirm the feasibility of a clinical study.
Cohort discovery via ACT is available to faculty and employees engaged in research at Tufts MC. Please use the standard form to request assistance.
To request support or use of our resources, please submit a service request.
Have questions? Please email email@example.com and we will be happy to assist you.
William Harvey, MD, MSc, FACR, Co-Director, Informatics
Andrew Williams, PhD, Co-Director, Informatics
Svetlana Rojevsky, MSc, Program Administrative Director, Informatics